AMAG Pharmaceuticals Aktie

AMAG Pharmaceuticals für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A0MXU2 / ISIN: US00163U1060

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
25.02.2016 18:10:00

AMAG Pharmaceuticals, Inc. -- Moody's: AMAG's Single Dose, Preservative Free Makena approval by the FDA is credit positive; ratings unaffected

New York, February 25, 2016 -- Moody's Investors Service commented that the FDA's approval of AMAG's single-dose, preservative-free formulation for Makena (hydroxyprogesterone caproate injection) is credit positive. However there is no effect on AMAG's current B2 Corporate Family Rating. The rating outlook is positive.

Vollständigen Artikel bei Moodys lesen